Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
塔芬諾喹治療巴貝斯蟲病的60度製藥臨床試驗將在塔夫茨醫學中心開始招生;同類研究中的第一項
Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
塔芬諾喹治療巴貝斯蟲病的60度製藥臨床試驗將在塔夫茨醫學中心開始招生;同類研究中的第一項
譯文內容由第三人軟體翻譯。